[Horse product].
Boissevain
Iaira
I
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D002404:Catheterization / Q000009:adverse effects / Q000662:veterinary; D003085:Colic / Q000188:drug therapy / Q000662:veterinary*; D006734:Horse Diseases / Q000188:drug therapy*; D006736:Horses; D007880:Legislation, Drug; D007886:Legislation, Veterinary; D008297:Male; D009426:Netherlands; D010653:Phenylbutazone / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome; D014730:Veterinary Medicine / Q000379:methods / Q000592:standards*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010653:Phenylbutazone